Effect of Hydroxychloroquine on Lupus Activity, Preeclampsia and Intrauterine Growth Restriction in Pregnant Women with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis
Background: Hydroxychloroquine (HCQ) has been used in the treatment of systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), but its effect on lupus activity during pregnancy, preeclampsia and intrauterine growth restriction (IUGR) remains unclear. Methods: PubMed, Embase and Coc...
Main Authors: | Zhengyan Hu, Rui Gao, Wanrong Huang, Huiqing Wang, Lang Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/2/485 |
Similar Items
-
New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
by: Chanchal Gera, et al.
Published: (2014-01-01) -
Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
by: Creso Abreu Falcão, et al.
Published: (2002-09-01) -
Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine
by: Valentina Canti, et al.
Published: (2021-07-01) -
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01) -
Primary antiphospholipid syndrome progressing to systemic lupus erythematosus: a case report
by: Rocco Manganelli, et al.
Published: (2013-04-01)